Haemonetics Corp reports results for the quarter ended in September - Earnings Summary

Haemonetics

02/11/2023 11:44

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
99 cents​​ per share for the quarter ended in September, higher
than the same quarter last year, when the company reported EPS
of 83 cents.  The mean expectation of eight analysts for the
quarter was for earnings of 89 cents per share. Wall Street
expected results to range from 83 cents to 97 cents per share.
    * Revenue rose 7% to $318.18 million from a year ago;
analysts
expected $313.12 million. 
    * Haemonetics Corp's reported EPS for the quarter was 48
cents​.
    * The company reported quarterly net income of $24.91
million.
    * Haemonetics Corp shares had fallen by 3.6% this
quarter and
gained 9.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $112.00 

This summary was machine generated from LSEG data November 2 at
11:44 a.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.89           0.99           Beat
 Jun. 30 2023      0.73           1.05           Beat
 Mar. 31 2023      0.70           0.77           Beat
 Dec. 31 2022      0.80           0.85           Beat